The short version
Just 2 companies supply this market — thin enough that a single exit would be felt immediately.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Bexagliflozin
Bexagliflozin · BEXAGLIFLOZIN 20 mg/1 · Tablet · Oral · TheracosBio, LLC
NDC 82381-2000-08 · 30 TABLET in 1 BOTTLE · NDA AUTHORIZED GENERIC · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- NDA214373
- TE code
- —
- Approval date
- Jan 20, 2023
- Patents / exclusivity
- 7 patents, 1 exclusivities
| Type | Number / code | Expires |
|---|---|---|
| exclusivity | NCE | Jan 20, 2028 |
| patent | 12594243 | Oct 5, 2041 |
| patent | 8987323 | May 14, 2032 |
| patent | 10533032 | Jul 3, 2031 |
| patent | 10981942 | Jun 13, 2031 |
| patent | 7838499 | Jan 30, 2029 |
| patent | 8106021 | Aug 22, 2028 |
| patent | 8802637 | Aug 22, 2028 |
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Bexagliflozin (Tablet)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Golden State Medical Supply, Inc. | BEXAGLIFLOZIN 20 mg/1 | Jul 15, 2026 | Sep 2, 2026 |
| TheracosBio, LLC | BEXAGLIFLOZIN 20 mg/1 | Jul 15, 2026 | Aug 31, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Bexagliflozin — NDC 82381-2000-08," retrieved September 3, 2026, https://drugdashboards.com/drug/82381200008.
Free to cite with attribution — see how the data is put together.